BioMarin Pharmaceutical is an international producer of innovative biopharmaceuticals for rare genetic diseases. The company’s developments provide significant advances for patients with rare, life-threatening diagnoses. BioMarin introduces new treatments to the market, providing enormous help to adults and children with serious inherited conditions that have few treatment options. Lately, the company has been named as one of the fastest developers of medicines. BioMarin trades on the NASDAQ stock exchange under the BMRN ticker. Browse the latest BioMarin share price chart and explore the most current BMRN stock news at Capital.com.
Shares and the pound sent mixed signals this morning ahead of a critical Brexit vote in Parliament later today. There are fears that the expected rejection by MPs of the government’s proposed Brexit deal could spark a constitutional crisis.
Learn moreCapital.com makes the majority of it’s money through the spread, the difference between the buy and sell price.
Shares are available to trade with up to 5:1 leverage. Start trading with as little as $100 to control a position of $500
Trade 24/5 on a wide range of shares
Buy and sell shares to take advantage of rises and falls in price
You can easily define Stops and Limits to request positions to close at a specified price.
Set up price alerts to be informed of big moves.
